GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hetzer Medical Indonesia Tbk PT MEDS.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

58

+1.75%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hetzer Medical Indonesia Tbk PT

Its shares trade on IDX under the ticker MEDS.JK. It has been listed since 10 August 2022. In the fiscal year to 31 December 2025, it reported revenue of IDR 6.63bn and a net loss of IDR 8.35bn. At that date it held total assets of IDR 61.77bn and shareholders' equity of IDR 48.30bn.

PT Hetzer Medical Indonesia engages in in production of masks and other medical supplies. The company is headquartered in Cimahi, Jawa Barat. The company went IPO on 2022-08-10. The firm also produces and distributes hand sanitizers. The company manufactures masks using an advanced technology. The company distributes its products under Evo Plusmed brand. Evo Plusmed manufactures masks with four-dimensional (4D) designs in Indonesia. The firm's products include Evo Surgical Mask 3 Ply, Evo Plusmed 4D Color Edition, Evo Plusmed 4D Super Edition, Evo Plusmed 4D Special Edition, Evo Plusmed 4D Mask 5 Ply, Evo Mask Hijab Series, Evo Mask For Kids, Evo Antiseptic Handrub and Evo Plusmed Spark Edition. The firm's factory is located in Cimahi Bandung.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
10 Aug 2022
Employees
27

Leadership

Pay as last reported

  • Mr. Jemmy KurniawanPresident Commissioner
  • Mr. A. Padmono SanyotoPresident Director
  • Ms. Fancy MarsianaDirector of Finance
  • Mr. Franciscus RijadiDirector of Operations
  • Mr. Alexander ..Commissioner
  • Mr. Suprapto TattooIndependent Commissioner

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company produces masks using advanced technology in Indonesia.
  • The firm distributes products under the Evo Plusmed brand.
  • Factory operations are located in Cimahi Bandung for efficiency.

Weaknesses

  • The company employs only 27 full-time staff members.
  • Operations are limited to the Indonesian domestic market.
  • Product range focuses heavily on masks and sanitizers.

Opportunities

  • Growing demand for medical supplies in Southeast Asia.
  • Expansion of the Evo Plusmed brand internationally.
  • Increasing need for advanced four-dimensional mask designs.

Threats

  • Intense competition from other mask manufacturers in Indonesia.
  • Fluctuating raw material costs for medical production.
  • Changing regulations regarding health care product standards.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.